Adam Levy
Director of Finance/CFO at MINERALYS THERAPEUTICS, INC.
Net worth: 5 M $ as of 2024-04-29
Profile
Adam S.
Levy is currently the Director at Praxis Bioresearch LLC and the Chief Financial Officer & Secretary at Mineralys Therapeutics, Inc. He previously held positions as the Chief Business Officer at Vical, Inc., Vice President-Healthcare Investment Banking at Wedbush Securities, Inc., Chief Business Officer at Brickell Subsidiary, Inc., Chief Financial Officer at Sanifit Therapeutics SA, Senior Vice President at Merrill Lynch, Pierce, Fenner & Smith, Inc., and Chief Business Officer at Viridian Therapeutics, Inc. He also served as the Chief Business Officer at Fresh Tracks Therapeutics, Inc. Mr. Levy completed his undergraduate degree at Cornell University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2024-03-14 | 445,684 ( 0.90% ) | 5 M $ | 2024-04-29 |
Adam Levy active positions
Companies | Position | Start |
---|---|---|
MINERALYS THERAPEUTICS, INC. | Director of Finance/CFO | 2022-02-28 |
Praxis Bioresearch LLC
Praxis Bioresearch LLC Pharmaceuticals: MajorHealth Technology Praxis Bioresearch LLC is a biopharmaceutical company based in the United States. The American company is focused on the discovery and development of therapeutics for chronic neuropsychiatric and neurodegenerative disorders. Praxis's lead development candidate is PRX-P4-003, a novel prodrug stimulant designed to offer the proven clinical activity of currently marketed stimulants while reducing the risk of abuse and addiction. PRX-P4-003 is being developed for the treatment of binge eating disorder and apathy in Alzheimer's disease. Sebastián Bernales and Sandeep Patil have been the CEOs since 2014. The private company was founded in 2014 by Sebastián Bernales, Rick E. Winningham, and Sandeep Patil. | Director/Board Member | 2023-09-18 |
Former positions of Adam Levy
Companies | Position | End |
---|---|---|
Sanifit Therapeutics SA
Sanifit Therapeutics SA BiotechnologyHealth Technology Sanifit Therapeutics SA develops pharmaceuticals for calcification disorders. Its pipeline consists of treatments for calcification disorders, such as calciphylaxis and osteoporosis. The company was founded by Felix Grases in 2004 and is headquartered in Palma de Mallorca, Spain. | Director of Finance/CFO | 2021-12-31 |
Brickell Subsidiary, Inc.
Brickell Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Brickell Subsidiary, Inc. operates as a clinical-stage pharmaceutical company. It focuses on the development of differentiated, innovative drug therapies for the treatment of skin diseases. The firm specializes in Hyperhidrosis, Cutaneous T-Cell Lymphoma and Psoriasis areas. The company was founded by Reginald L. Hardy and Andrew D. Sklawer in November 2009 and is headquartered in Boulder, CO. | Corporate Officer/Principal | 2019-12-31 |
VIRIDIAN THERAPEUTICS, INC. | Investor Relations Contact | - |
VIRIDIAN THERAPEUTICS, INC. | Corporate Officer/Principal | 2018-12-31 |
Merrill Lynch, Pierce, Fenner & Smith, Inc.
Merrill Lynch, Pierce, Fenner & Smith, Inc. Investment Banks/BrokersFinance Founded in 1958, Merrill Lynch Piece Fenner & Smith, Inc. is an SEC registered broker/dealer located in New York City. The firm is a subsidiary of BAC North America Holding Co. and their ultimate parent is Bank of America Corp. (NYSE BAC). | Corporate Officer/Principal | 2016-04-30 |
Training of Adam Levy
Cornell University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
VIRIDIAN THERAPEUTICS, INC. | Health Technology |
FRESH TRACKS THERAPEUTICS, INC. | Health Technology |
MINERALYS THERAPEUTICS, INC. | Health Technology |
Private companies | 6 |
---|---|
Vical, Inc.
Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. | Health Technology |
Wedbush Securities, Inc.
Wedbush Securities, Inc. Investment Banks/BrokersFinance Wedbush Securities, Inc. is a full-service investment bank and brokerage firm headquartered in Los Angeles, California. The firm was founded in 1955 as Wedbush Morgan Securities, Inc. They are a subsidiary of Wedbush Financial Services LLC, which is owned by Wedbush, Inc. Wedbush Securities provides a wide range of securities brokerage, wealth management, and investment banking services to private and institutional clients. Their research focuses on providing coverage of small and mid-sized companies in the following industries: (1) consumer products and services (2) technology (3) entertainment and media (4) life sciences and (5) industrial growth and clean technology. | Finance |
Brickell Subsidiary, Inc.
Brickell Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Brickell Subsidiary, Inc. operates as a clinical-stage pharmaceutical company. It focuses on the development of differentiated, innovative drug therapies for the treatment of skin diseases. The firm specializes in Hyperhidrosis, Cutaneous T-Cell Lymphoma and Psoriasis areas. The company was founded by Reginald L. Hardy and Andrew D. Sklawer in November 2009 and is headquartered in Boulder, CO. | Health Technology |
Sanifit Therapeutics SA
Sanifit Therapeutics SA BiotechnologyHealth Technology Sanifit Therapeutics SA develops pharmaceuticals for calcification disorders. Its pipeline consists of treatments for calcification disorders, such as calciphylaxis and osteoporosis. The company was founded by Felix Grases in 2004 and is headquartered in Palma de Mallorca, Spain. | Health Technology |
Praxis Bioresearch LLC
Praxis Bioresearch LLC Pharmaceuticals: MajorHealth Technology Praxis Bioresearch LLC is a biopharmaceutical company based in the United States. The American company is focused on the discovery and development of therapeutics for chronic neuropsychiatric and neurodegenerative disorders. Praxis's lead development candidate is PRX-P4-003, a novel prodrug stimulant designed to offer the proven clinical activity of currently marketed stimulants while reducing the risk of abuse and addiction. PRX-P4-003 is being developed for the treatment of binge eating disorder and apathy in Alzheimer's disease. Sebastián Bernales and Sandeep Patil have been the CEOs since 2014. The private company was founded in 2014 by Sebastián Bernales, Rick E. Winningham, and Sandeep Patil. | Health Technology |
Merrill Lynch, Pierce, Fenner & Smith, Inc.
Merrill Lynch, Pierce, Fenner & Smith, Inc. Investment Banks/BrokersFinance Founded in 1958, Merrill Lynch Piece Fenner & Smith, Inc. is an SEC registered broker/dealer located in New York City. The firm is a subsidiary of BAC North America Holding Co. and their ultimate parent is Bank of America Corp. (NYSE BAC). | Finance |
- Stock Market
- Insiders
- Adam Levy